SICKLE CELL ANAEMIA
Clinical trials for SICKLE CELL ANAEMIA explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL ANAEMIA trials appear
Sign up with your email to follow new studies for SICKLE CELL ANAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could boost red blood cells in sickle cell patients
Disease control Not yet recruitingThis study tests an experimental drug called SIL-8301 (senicapoc) in people with sickle cell disease who have low hemoglobin and few pain crises. About 105 participants aged 16-35 will take either the drug or a placebo daily for 24 weeks, while continuing their usual hydroxyurea …
Matched conditions: SICKLE CELL ANAEMIA
Phase: PHASE2 • Sponsor: Biossil Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New blood processing method could mean fewer transfusions for sickle cell patients
Disease control Not yet recruitingThis study tests whether red blood cells processed with the Hemanext ONE® system (hypoxic RBCs) last longer in the body compared to standard blood transfusions for people with sickle cell anemia. About 48 participants aged 7 and older who need regular transfusions will receive bo…
Matched conditions: SICKLE CELL ANAEMIA
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated May 07, 2026 18:39 UTC